A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey

Helicobacter

Volumn 12, Issue 6, 2007, Pages 629-632

  Sezgin, Orhan ^a,b   Altintaş, Engin ^a   Nayir, Erdinç ^a   Üçbilek, Enver ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Eradication therapy; Helicobacter pylori; Sequential therapy

Indexed keywords

AMOXICILLIN; CARBON 11; METRONIDAZOLE; PANTOPRAZOLE; TETRACYCLINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; TURKEY (REPUBLIC); UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PATIENT COMPLIANCE; PILOT PROJECTS; TETRACYCLINE; TURKEY;

HELICOBACTER PYLORI;

EID: 36349000617     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00547.x     Document Type: Article

References (30)

1. Logan RPH, Walker MM. Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 2001 323 : 920 2.
2. Sipponen P, Hyvȧrinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993 28 (Suppl 196 3 6.
3. Stolte M, Edit S. Healing gastric MALT lymphoma by eradication of H. pylori. Lancet 1993 342 : 568.
4. Akin L, Tezcan S, Hasçelik G, Çakir B. Seroprevalence and some correlates of Helicobacter pylori at adult ages in Gülveren Health District, Ankara, Turkey. Epidemiol Infect 2004 132 : 847 56.
5. Özden A, Dumlu Ş, Dönderici Ö, Çetinkaya H, Soylu K, Özkan H. Helicobacter pylori infeksiyonunun ülkemizde seroepidemiyolojisi (Helicobacter pylori seroepidemiology in Turkey). Gastroenteroloji 1992 3 : 664 8.
6. Karaaslan H, Bektaş M, Soykan İ, Bozkaya H, Bahar K, Özden A. Türkiyede gönüllü kan donörlerinde Helicobacter pylori seroprevelansi (Helicobacter pylori seroprevalence in blood donors in Turkey). Turk J Gastroenterol 2003 Suppl SB.03/1.
7. Malfertheiner P, Megraud F, O'morion C, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002 16 : 167 180.
8. Altintaş E, Sezgin O, Ulu O, et al. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. World J Gastroenterol 2004 10 : 1656 8.
9. Gümürdülü Y, Serin E, Özer B, Kayaselçuk F, Özşahin K, Coşar AM. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadruple therapy in Turkey. World J Gastroenterol 2004 10 : 668 71.
10. Avşar E, Kaymakoǧlu S, Erzin Y, et al. Dispeptik hastalarda Hp eradikasyonunda 14 günlük ranitidin bizmut sitrat bazli tedavi ile lansoprazol bazli üçlü tedaviyi karşilaştiran çok merkezli, randomize, prospektif bir çalişma (A multicenter, randomised, prospective, comparative study for 14 days ranitidine bismuth citrate and lansoprazole based triple therapy in patients with dyspepsia for Helicobacter pylori eradication). Turk J Gastroenterol 2004 Suppl SB.10/1.
11. Önder GF, Aydin A, Doǧanavşargil B, et al. Hp infeksiyonunda pantoprazol, amoksisilin, klaritromisin kombinasyonu ile 1 ve 2 haftalik tedavilerin etkinliǧi (The effectiveness of one and two weeks pantoprazole, amoxicillin, clarithromycin combination treatments in Helicobacter pylori infection). Turk J Gastroenterol 2003 Suppl PB.08/44.
12. Sivri B, Şimşek İ, Hülagu S, et al. The efficacy, safety and tolerability of pantoprazole based one-week triple therapy in Helicobacter pylori eradication and duodenal ulcer healing. Curr Med Res Opin 2004 20 : 1301 7.
13. Güliter S, Keleş H, Özkurt ZN, Cengiz DU, Kolukisa E. Can lansoprazole, amoxicillin and clarithromycin combination still be used as a first-line therapy for eradication of Helicobacter pylori? Turk J Gastroenterol 2005 16 : 29 33.
14. Uygun A, Yeşilova Z, Ateş Y, et al. Helicobacter pylori pozitif non-ülser dispepsili hastalarda Hp eradikasyon tedavisinde 14 ve 7 günlük lansoprazol, amoksisilin, klaritromisin tedavi protokollerinin karşilaştirilmasi (Comparison of 14 and 7 days lansoprazole, amoxicillin, chlarithromycin treatment protocols in patients with Helicobacter pylori positive non-ulcer dyspepsia). Turk J Gastroenterol 2004 Suppl PB.08/15.
15. Ertaş E, Tüzün A, Özden A. Helicobacter pylori pozitif fonksiyonel dispepside 7 ve 14 günlük pantoprazol, klaritromisin, amoksisilin kombinasyon tedavisinin eradikasyon etkinlişinin ve eradikasyonun dispeptik semptomlar üzerine etkilerinin deǧerlendirilmesi. (Effectiveness of 7 and 14 days pantoprazole, amoxicillin, clarithromycin combination treatments in Helicobacter pylori positive functional dyspepsia). Turk J Gastroenterol 2004 Suppl PB.08/18.
16. Uygun A, Kadayifçi A, Yeşilova Z, et al. Hp eradikasyonunda lansoprazol ve pantoprazol içeren üçlü rejimlerin etkinliǧinin karşilaştirilmasi (Comparison of effectiveness of lansoprazole and pantoprazole based triple therapy in Helicobacter pylori eradication). Turk J Gastroenterol 2003 Suppl PB.08/33.
17. Ünsal B, Ekinci N, Altinay A, et al. Helicobacter pylori nin klirensinde üçlü tedavinin etkinliǧi (Efficacy of triple therapy in Helicobacter pylori eradication). Turk J Gastroenterol 1993 4 : 284 6.
18. Sezgin O, Altintaş E, Üçbilek E, Tataroǧlu C. Bismuth-based therapies for the first-step eradication of Helicobacter pylori. Turk J Gastroenterol 2006 17 : 90 93.
19. Özer B, Coşar A, Serin E, et al. Helicobacter pylori tedavisinde bizmut içeren dörtlü tedavi rejimiyle düşük eradikasyon oranlari (Low eradication rates with bismuth based quadruple therapy in Helicobacter pylori treatment). Turk J Gastroenterol 2004 Suppl PB.08/39.
20. Ataseven H, Mar N, Bahçecioǧlu HI, et al. Hp eradikasyonunda 14 günlük ranitidin bizmut sitrat, doksisiklin, amoksisilin ile pantoprazol, doksisiklin, amoksisilin tedavilerinin karşilaştirilmasi (Comparison of 14 days ranitidine bismuth citrate, doxicicline, amoxicillin and pantoprazole, doxicicline, amoxicillin in Helicobacter pylori eradication). Turk J Gastroenterol 2004 Suppl PB.08/57.
21. Uygun A, Yeşilova Z, Erdil A, et al. Should sequential therapy be used in patients with Helicobacter pylori positive non-ulcer dyspepsia in first-line eradication. Turk J Gastroenterol 2005 16 (Suppl 1 SB.01/10.
22. Scwartz H, Krause R, Sahba B, et al. Triple versus dual therapy eradication of Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxycillin in different dosing regimens. Am J Gastroenterol 1998 93 : 584 90.
23. Tursi A, Cammarota G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996 10 : 285 8.
24. Spinzi GC, Bierty L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998 12 : 433 8.
25. Labenz J, Stolte M, Peitz U, et al. One-week triple therapy with omeprazole, amoxycillin and clarithromycin or metranidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996 10 : 207 10.
26. Bigard MA, Delchier JC, Riachi G, et al. One week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia: influence of dosage of amoxycillin and clarithromycin. Aliment Pharmacol Ther 1998 12 : 383 8.
27. Sezgin O, Aslan G, Altinta E, Tezcan S, Serin MS, Emekdaş G. Detection of point mutation on 23S rRNA in Helicobacter pylori and clarithromycin resistance by PCR-RFLP in gastric biopsy specimens in Mersin. Turk J Gastroenterol 2006 17 (Suppl 1 SB.07/01.
28. Sezgin O, Altintaş E, Üçbilek E, Tombak A, Tellioǧlu B. In effectiveness of moxifloxacin-based Helicobacter pylori eradication treatment in Turkish population. Turk J Gastroenterol 2005 16 (Suppl 1 SB.01/1.
29. Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003 17 : 719 26.
30. de Boer WA, Tytgat GNJ. Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis? Eur J Gastroenterol Hepatol 2001 13 : 1281 4.